AbCellera Investor Conference Presentation Deck
May 2022, 25 slides
  1. AbCellera
  2. Related Decks
  3. Investor Conference Presentation Decks
corporate overview bloom burton investor conference may oss | AbCellera
disclaimer | AbCellera
we are a technology company was founded after spending more than years working on for research wanted our work to really matter looked for the place where makes the difference | AbCellera
immunology is the killer for for single cell analysis for yrs approved drugs blockbusters | AbCellera
long expensive risky | AbCellera
target to is one of the most complex technology intensive paths in any sector target identification drug discovery clinical development ideation a product testing | AbCellera
technology for discovery has been neglected | AbCellera
can it be built better existing are unintentionally as a by product of drug development and are still based on from the if you make this your business if you start from a clean slate and take advantage of modern technologies is obvious that you build a much front end for therapeutic antibody drug development | AbCellera
is it valuable accelerating approval of an average antibody drug by year could be worth more than in drugging the could unlock billion in new market opportunities being first to market could easily be billions in sales profit and value saving small from reinventing the wheel could be worth more than million eer | AbCellera
be the best in the world from target to engine we wae faster solve unsolvable highest quality unprecedented scale | AbCellera
strategy dictates the business model we are building a large diversified portfolio that we believe will generate long term value and superior returns without the volatility and risks normally associated with drug development | AbCellera
it incredibly hard in hindsight the honest pitch in to rebuild the front end of would have been years billion its woe a no surprise no one wanted invest | AbCellera
over in equity non dilutive capital | AbCellera
validated the platform capital to complete the stack developed two antibody treatments authorized by the to treat covid | AbCellera
are pulling back we investing in the future yate tae an | AbCellera
we created a best in world technology from drug target to lead candidate source search decode analyze engineer deliver teem | AbCellera
source search decode analyze engineer | AbCellera
forward integration to accelerate drug development meal | AbCellera
unlocking new drug classes with tech recent acquisitions successfully integrated into our tech stack are being leveraged to unlock new programs it i aloes nag | AbCellera
partnering with the best drug developers of all sizes we forge partnerships with large cap pharmaceutical companies companies of all sizes and non profit and government organizations through flexible deal structures royalties milestones equity equity like option to invest | AbCellera
illustrative revenue profile for one successful partnered program participation in programs is strongly weighted towards downstream success i a | AbCellera
large diversified portfolio in next gen antibody therapies of programs with downstream participation is across the following therapeutic areas ere eel | AbCellera
focussed on key value drivers probability of success speed portfolio volume deal structures col | AbCellera
we a one of a kind company with familiar themes build value through a diverse portfolio of future revenue streams create a competitive advantage through vertical integration make long term investments in technology to accelerate development or amen | AbCellera
thank you | AbCellera
See More
AbCellera
Investor Conference Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Downstream
Drug development
Drug candidate
Drug discovery
Recent decks by AbCellera
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
See all presentations by AbCellera (23 decks)
Related decks
BenevolentAI
SPAC
December 2021
Absci
Investor Conference
January 2023
Absci
Investor Presentation
October 2023
Absci
IPO
July 2021
Absci
Investor Presentation
July 2023
Absci
Investor Presentation
March 2023
BenevolentAI
Investor Presentation
October 2022
ATAI
Investor Presentation
June 2020
Recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
BenevolentAI
SPAC
December 2021
Absci
Investor Conference
January 2023
Absci
Investor Presentation
October 2023
Absci
IPO
July 2021
Absci
Investor Presentation
July 2023
Absci
Investor Presentation
March 2023
BenevolentAI
Investor Presentation
October 2022
ATAI
Investor Presentation
June 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io